Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 373 entries
View as:

A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT00835926 Org: User:
Start: 07/31/03 End: 09/30/03 Due: 09/30/04

Influenza Vaccine Revaccination in Ambulatory Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00775450 Org: User:
Start: 10/31/08 End: 07/31/09 Due: 07/31/10

Study of Safety and Immunogenicity of Fluzone® in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT00831675 Org: User:
Start: 09/30/04 End: 04/30/06 Due: 04/30/07

Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®

Phase: N/A Priority: Normal
NCT ID: NCT00258895 Org: User:
Start: 03/31/05 End: 04/30/07 Due: 04/30/08

Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT01430611 Org: User:
Start: 08/31/11 End: 11/30/12 Due: 11/30/13

Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®

Phase: N/A Priority: Normal
NCT ID: NCT00850603 Org: User:
Start: 10/31/02 End: 11/30/04 Due: 11/30/05

Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines

Phase: N/A Priority: Normal
NCT ID: NCT01270503 Org: User:
Start: 12/31/10 End: 07/31/14 Due: 07/31/15

Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations

Phase: N/A Priority: Normal
NCT ID: NCT03617523 Org: User:
Start: 09/10/18 End: 11/12/18 Due: 11/12/19

Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV

Phase: N/A Priority: Normal
NCT ID: NCT00362336 Org: User:
Start: 08/31/06 End: 08/31/09 Due: 08/31/10

Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year

Phase: N/A Priority: Normal
NCT ID: NCT03700242 Org: User:
Start: 09/26/18 End: 04/08/20 Due: 04/08/21

A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China

Phase: N/A Priority: Normal
NCT ID: NCT01278433 Org: User:
Start: 12/31/10 End: 06/30/12 Due: 06/30/13

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT05553301 Org: User:
Start: 10/03/22 End: 01/19/24 Due: 01/19/25

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years

Phase: N/A Priority: Normal
NCT ID: NCT05513391 Org: User:
Start: 11/10/22 End: 10/03/23 Due: 10/03/24

Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03391193 Org: User:
Start: 12/19/17 End: 08/25/18 Due: 08/25/19

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00287092 Org: User:
Start: 02/28/06 End: 09/30/08 Due: 09/30/09

Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.

Phase: N/A Priority: Normal
NCT ID: NCT01993173 Org: User:
Start: 11/30/13 End: 04/30/15 Due: 04/30/16

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Phase: N/A Priority: Normal
NCT ID: NCT00831311 Org: User:
Start: 10/31/04 End: 03/31/07 Due: 03/31/08

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants

Phase: N/A Priority: Normal
NCT ID: NCT00514709 Org: User:
Start: 09/30/07 End: 04/30/09 Due: 04/30/10

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Phase: N/A Priority: Normal
NCT ID: NCT00389857 Org: User:
Start: 10/31/06 End: 07/31/08 Due: 07/31/09

Dose Comparison Study of Menactra® in US Children

Phase: N/A Priority: Normal
NCT ID: NCT00700635 Org: User:
Start: 06/30/08 End: 10/31/09 Due: 10/31/10

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT05426174 Org: User:
Start: 06/09/22 End: 01/03/24 Due: 01/03/25

Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT01129362 Org: User:
Start: 02/08/10 End: 12/30/14 Due: 12/30/15

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02628444 Org: User:
Start: 05/02/16 End: 04/29/20 Due: 04/29/21

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT04210349 Org: User:
Start: 01/09/20 End: 12/01/20 Due: 12/01/21

Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults

Phase: N/A Priority: Normal
NCT ID: NCT01430819 Org: User:
Start: 09/30/11 End: 02/29/12 Due: 02/28/13